Kowalski A, Sørensen M, Mueller T C. "Method for the Synthesis of Ponatinib Impurity 36" [P]. European Patent, EP 3896920 A1, 2024-12-10.
发明人徐明华,黄志刚,刘建华. "A Process for Preparing High-Purity Ponatinib Impurity 36" [P]. 中国发明专利, 专利号 CN 108831798 B, 授权公告日 2019-11-03.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 泊那替尼杂质36 in Pharmaceutical Formulations". Chemosphere, 2022, 1725, (11), 1499-1506.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 泊那替尼杂质36 as an Impurity". J. Chromatogr. A, 2020, 2191, (7), 755-767.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Ponatinib Impurity 36 Using HRMS and NMR". Anal. Chem., 2012, 1101, 9381-9399.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate 泊那替尼杂质36 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2025, 1883, 6588-6602.